nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—Suicide—Sorafenib—liver cancer	0.0301	0.077	CcSEcCtD
Vilazodone—Completed suicide—Sorafenib—liver cancer	0.0265	0.0679	CcSEcCtD
Vilazodone—CYP2D6—Sorafenib—liver cancer	0.0161	0.381	CbGbCtD
Vilazodone—Hyponatraemia—Sorafenib—liver cancer	0.0114	0.0291	CcSEcCtD
Vilazodone—CYP3A4—Sorafenib—liver cancer	0.0102	0.242	CbGbCtD
Vilazodone—Breast disorder—Sorafenib—liver cancer	0.0102	0.0262	CcSEcCtD
Vilazodone—CYP2D6—Doxorubicin—liver cancer	0.00976	0.231	CbGbCtD
Vilazodone—Erectile dysfunction—Sorafenib—liver cancer	0.00901	0.0231	CcSEcCtD
Vilazodone—Connective tissue disorder—Sorafenib—liver cancer	0.0077	0.0197	CcSEcCtD
Vilazodone—Cardiac disorder—Sorafenib—liver cancer	0.00727	0.0186	CcSEcCtD
Vilazodone—Mental disorder—Sorafenib—liver cancer	0.00686	0.0176	CcSEcCtD
Vilazodone—Malnutrition—Sorafenib—liver cancer	0.00682	0.0175	CcSEcCtD
Vilazodone—Dysgeusia—Sorafenib—liver cancer	0.00668	0.0171	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Epirubicin—liver cancer	0.00638	0.0163	CcSEcCtD
Vilazodone—CYP3A4—Doxorubicin—liver cancer	0.00621	0.147	CbGbCtD
Vilazodone—Ventricular extrasystoles—Doxorubicin—liver cancer	0.0059	0.0151	CcSEcCtD
Vilazodone—Arthralgia—Sorafenib—liver cancer	0.0058	0.0149	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00576	0.0148	CcSEcCtD
Vilazodone—Abnormal dreams—Epirubicin—liver cancer	0.0057	0.0146	CcSEcCtD
Vilazodone—Dry mouth—Sorafenib—liver cancer	0.00568	0.0145	CcSEcCtD
Vilazodone—Nervous system disorder—Sorafenib—liver cancer	0.00546	0.014	CcSEcCtD
Vilazodone—Skin disorder—Sorafenib—liver cancer	0.0054	0.0138	CcSEcCtD
Vilazodone—Dry eye—Epirubicin—liver cancer	0.00532	0.0136	CcSEcCtD
Vilazodone—Abnormal dreams—Doxorubicin—liver cancer	0.00527	0.0135	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00507	0.013	CcSEcCtD
Vilazodone—Dry eye—Doxorubicin—liver cancer	0.00492	0.0126	CcSEcCtD
Vilazodone—Dyspepsia—Sorafenib—liver cancer	0.0049	0.0125	CcSEcCtD
Vilazodone—Decreased appetite—Sorafenib—liver cancer	0.00484	0.0124	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Sorafenib—liver cancer	0.0048	0.0123	CcSEcCtD
Vilazodone—Fatigue—Sorafenib—liver cancer	0.0048	0.0123	CcSEcCtD
Vilazodone—Increased appetite—Epirubicin—liver cancer	0.00445	0.0114	CcSEcCtD
Vilazodone—Hyponatraemia—Epirubicin—liver cancer	0.0042	0.0108	CcSEcCtD
Vilazodone—Increased appetite—Doxorubicin—liver cancer	0.00412	0.0105	CcSEcCtD
Vilazodone—Migraine—Epirubicin—liver cancer	0.00412	0.0105	CcSEcCtD
Vilazodone—Asthenia—Sorafenib—liver cancer	0.00399	0.0102	CcSEcCtD
Vilazodone—Hyponatraemia—Doxorubicin—liver cancer	0.00389	0.00995	CcSEcCtD
Vilazodone—Migraine—Doxorubicin—liver cancer	0.00381	0.00975	CcSEcCtD
Vilazodone—Diarrhoea—Sorafenib—liver cancer	0.00381	0.00975	CcSEcCtD
Vilazodone—Breast disorder—Epirubicin—liver cancer	0.00378	0.00968	CcSEcCtD
Vilazodone—Dizziness—Sorafenib—liver cancer	0.00368	0.00942	CcSEcCtD
Vilazodone—Vomiting—Sorafenib—liver cancer	0.00354	0.00906	CcSEcCtD
Vilazodone—Breast disorder—Doxorubicin—liver cancer	0.0035	0.00896	CcSEcCtD
Vilazodone—Pollakiuria—Epirubicin—liver cancer	0.00334	0.00855	CcSEcCtD
Vilazodone—Nausea—Sorafenib—liver cancer	0.0033	0.00846	CcSEcCtD
Vilazodone—Pollakiuria—Doxorubicin—liver cancer	0.00309	0.00791	CcSEcCtD
Vilazodone—Connective tissue disorder—Epirubicin—liver cancer	0.00284	0.00728	CcSEcCtD
Vilazodone—Eye disorder—Epirubicin—liver cancer	0.0027	0.00692	CcSEcCtD
Vilazodone—Cardiac disorder—Epirubicin—liver cancer	0.00269	0.00688	CcSEcCtD
Vilazodone—Connective tissue disorder—Doxorubicin—liver cancer	0.00263	0.00674	CcSEcCtD
Vilazodone—Mental disorder—Epirubicin—liver cancer	0.00254	0.00649	CcSEcCtD
Vilazodone—Malnutrition—Epirubicin—liver cancer	0.00252	0.00645	CcSEcCtD
Vilazodone—Eye disorder—Doxorubicin—liver cancer	0.0025	0.00641	CcSEcCtD
Vilazodone—Cardiac disorder—Doxorubicin—liver cancer	0.00249	0.00636	CcSEcCtD
Vilazodone—Flatulence—Epirubicin—liver cancer	0.00248	0.00636	CcSEcCtD
Vilazodone—Dysgeusia—Epirubicin—liver cancer	0.00247	0.00632	CcSEcCtD
Vilazodone—Nervousness—Epirubicin—liver cancer	0.00245	0.00626	CcSEcCtD
Vilazodone—Vision blurred—Epirubicin—liver cancer	0.00237	0.00608	CcSEcCtD
Vilazodone—Mental disorder—Doxorubicin—liver cancer	0.00235	0.00601	CcSEcCtD
Vilazodone—Malnutrition—Doxorubicin—liver cancer	0.00233	0.00597	CcSEcCtD
Vilazodone—Agitation—Epirubicin—liver cancer	0.00232	0.00593	CcSEcCtD
Vilazodone—Flatulence—Doxorubicin—liver cancer	0.0023	0.00588	CcSEcCtD
Vilazodone—Dysgeusia—Doxorubicin—liver cancer	0.00228	0.00584	CcSEcCtD
Vilazodone—Nervousness—Doxorubicin—liver cancer	0.00226	0.0058	CcSEcCtD
Vilazodone—Palpitations—Epirubicin—liver cancer	0.00223	0.0057	CcSEcCtD
Vilazodone—Vision blurred—Doxorubicin—liver cancer	0.0022	0.00562	CcSEcCtD
Vilazodone—Convulsion—Epirubicin—liver cancer	0.00218	0.00559	CcSEcCtD
Vilazodone—Arthralgia—Epirubicin—liver cancer	0.00214	0.00549	CcSEcCtD
Vilazodone—Agitation—Doxorubicin—liver cancer	0.00214	0.00548	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00213	0.00545	CcSEcCtD
Vilazodone—Dry mouth—Epirubicin—liver cancer	0.0021	0.00537	CcSEcCtD
Vilazodone—Palpitations—Doxorubicin—liver cancer	0.00206	0.00527	CcSEcCtD
Vilazodone—Convulsion—Doxorubicin—liver cancer	0.00202	0.00517	CcSEcCtD
Vilazodone—Nervous system disorder—Epirubicin—liver cancer	0.00202	0.00516	CcSEcCtD
Vilazodone—Skin disorder—Epirubicin—liver cancer	0.002	0.00511	CcSEcCtD
Vilazodone—Hyperhidrosis—Epirubicin—liver cancer	0.00199	0.00509	CcSEcCtD
Vilazodone—Arthralgia—Doxorubicin—liver cancer	0.00198	0.00508	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00197	0.00505	CcSEcCtD
Vilazodone—Dry mouth—Doxorubicin—liver cancer	0.00194	0.00497	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00187	0.0048	CcSEcCtD
Vilazodone—Nervous system disorder—Doxorubicin—liver cancer	0.00187	0.00478	CcSEcCtD
Vilazodone—Insomnia—Epirubicin—liver cancer	0.00186	0.00476	CcSEcCtD
Vilazodone—Skin disorder—Doxorubicin—liver cancer	0.00185	0.00473	CcSEcCtD
Vilazodone—Paraesthesia—Epirubicin—liver cancer	0.00185	0.00473	CcSEcCtD
Vilazodone—Hyperhidrosis—Doxorubicin—liver cancer	0.00184	0.00471	CcSEcCtD
Vilazodone—Somnolence—Epirubicin—liver cancer	0.00183	0.00468	CcSEcCtD
Vilazodone—Dyspepsia—Epirubicin—liver cancer	0.00181	0.00463	CcSEcCtD
Vilazodone—Decreased appetite—Epirubicin—liver cancer	0.00179	0.00458	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Epirubicin—liver cancer	0.00178	0.00454	CcSEcCtD
Vilazodone—Fatigue—Epirubicin—liver cancer	0.00177	0.00454	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00173	0.00444	CcSEcCtD
Vilazodone—Insomnia—Doxorubicin—liver cancer	0.00172	0.00441	CcSEcCtD
Vilazodone—Paraesthesia—Doxorubicin—liver cancer	0.00171	0.00437	CcSEcCtD
Vilazodone—Feeling abnormal—Epirubicin—liver cancer	0.00169	0.00434	CcSEcCtD
Vilazodone—Somnolence—Doxorubicin—liver cancer	0.00169	0.00433	CcSEcCtD
Vilazodone—Dyspepsia—Doxorubicin—liver cancer	0.00167	0.00429	CcSEcCtD
Vilazodone—Decreased appetite—Doxorubicin—liver cancer	0.00165	0.00423	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00164	0.00421	CcSEcCtD
Vilazodone—Fatigue—Doxorubicin—liver cancer	0.00164	0.0042	CcSEcCtD
Vilazodone—Feeling abnormal—Doxorubicin—liver cancer	0.00157	0.00401	CcSEcCtD
Vilazodone—Asthenia—Epirubicin—liver cancer	0.00148	0.00378	CcSEcCtD
Vilazodone—Diarrhoea—Epirubicin—liver cancer	0.00141	0.0036	CcSEcCtD
Vilazodone—Asthenia—Doxorubicin—liver cancer	0.00136	0.00349	CcSEcCtD
Vilazodone—Dizziness—Epirubicin—liver cancer	0.00136	0.00348	CcSEcCtD
Vilazodone—Vomiting—Epirubicin—liver cancer	0.00131	0.00335	CcSEcCtD
Vilazodone—Diarrhoea—Doxorubicin—liver cancer	0.0013	0.00333	CcSEcCtD
Vilazodone—Dizziness—Doxorubicin—liver cancer	0.00126	0.00322	CcSEcCtD
Vilazodone—Nausea—Epirubicin—liver cancer	0.00122	0.00313	CcSEcCtD
Vilazodone—Vomiting—Doxorubicin—liver cancer	0.00121	0.0031	CcSEcCtD
Vilazodone—Nausea—Doxorubicin—liver cancer	0.00113	0.00289	CcSEcCtD
Vilazodone—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.000619	0.00109	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.000613	0.00108	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000612	0.00108	CbGpPWpGaD
Vilazodone—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.00061	0.00108	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—IL6—liver cancer	0.000608	0.00107	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CRABP1—liver cancer	0.000605	0.00107	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—TRIO—liver cancer	0.000604	0.00107	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CCR4—liver cancer	0.000599	0.00106	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CCR4—liver cancer	0.000579	0.00102	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000563	0.000993	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000555	0.000979	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—TRIO—liver cancer	0.000549	0.000967	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—TP53—liver cancer	0.000542	0.000956	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.000538	0.000948	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—HPGDS—liver cancer	0.000529	0.000933	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CCR4—liver cancer	0.000526	0.000927	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—TNF—liver cancer	0.000525	0.000925	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000517	0.000912	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—JUN—liver cancer	0.000502	0.000886	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SHC3—liver cancer	0.000498	0.000879	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—IL6—liver cancer	0.000496	0.000875	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—MAPK8—liver cancer	0.000475	0.000838	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PSMA4—liver cancer	0.000471	0.000831	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PSMD10—liver cancer	0.000471	0.000831	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—F2—liver cancer	0.000467	0.000823	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000465	0.000819	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—UGDH—liver cancer	0.000463	0.000816	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GOT2—liver cancer	0.000459	0.000809	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000458	0.000808	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SHC3—liver cancer	0.000437	0.000771	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—EPT1—liver cancer	0.000435	0.000767	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CYP2E1—liver cancer	0.000431	0.00076	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000427	0.000753	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—IL6—liver cancer	0.000423	0.000746	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000421	0.000742	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TAT—liver cancer	0.000413	0.000727	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—F2—liver cancer	0.00041	0.000722	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000405	0.000713	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CYCS—liver cancer	0.000403	0.000711	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000399	0.000704	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GGT1—liver cancer	0.000396	0.000698	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GOT1—liver cancer	0.000396	0.000698	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FST—liver cancer	0.000387	0.000682	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PRKCE—liver cancer	0.00038	0.00067	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TRIO—liver cancer	0.000369	0.000651	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GSTP1—liver cancer	0.000356	0.000627	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCR4—liver cancer	0.000354	0.000624	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—HMOX1—liver cancer	0.000351	0.000618	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PRKCE—liver cancer	0.000345	0.000608	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FST—liver cancer	0.00034	0.000599	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—CSF2—liver cancer	0.000336	0.000592	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PRKCE—liver cancer	0.000333	0.000588	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—TP53—liver cancer	0.000332	0.000585	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GSTM1—liver cancer	0.000327	0.000576	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TRIO—liver cancer	0.000324	0.000571	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCR4—liver cancer	0.000311	0.000548	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CYP1A1—liver cancer	0.00031	0.000546	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CSF2—liver cancer	0.000305	0.000538	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—IL6—liver cancer	0.000303	0.000535	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PRKCE—liver cancer	0.000303	0.000534	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—UGDH—liver cancer	0.000303	0.000534	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CSF2—liver cancer	0.000295	0.00052	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—MTHFR—liver cancer	0.000289	0.000509	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—EPT1—liver cancer	0.000285	0.000502	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PPARA—liver cancer	0.000283	0.0005	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CPT1B—liver cancer	0.00028	0.000495	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GLUL—liver cancer	0.00028	0.000495	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADAM17—liver cancer	0.00028	0.000493	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NR1H4—liver cancer	0.00027	0.000477	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TAT—liver cancer	0.00027	0.000476	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CSF2—liver cancer	0.000268	0.000472	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTA3—liver cancer	0.000266	0.000469	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—F2—liver cancer	0.000264	0.000465	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PSMA4—liver cancer	0.000263	0.000464	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PSMD10—liver cancer	0.000263	0.000464	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CG—liver cancer	0.000252	0.000445	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADAM17—liver cancer	0.000246	0.000433	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTA4—liver cancer	0.000243	0.000429	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CG—liver cancer	0.000243	0.000428	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—F2—liver cancer	0.000239	0.000422	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTA2—liver cancer	0.000237	0.000418	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PPARG—liver cancer	0.000234	0.000413	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—F2—liver cancer	0.000231	0.000408	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PSMA4—liver cancer	0.000231	0.000407	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PSMD10—liver cancer	0.000231	0.000407	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CG—liver cancer	0.000229	0.000404	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTA1—liver cancer	0.000229	0.000403	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NAT2—liver cancer	0.000226	0.000399	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CD—liver cancer	0.000222	0.000391	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CG—liver cancer	0.000222	0.000391	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALDOB—liver cancer	0.000217	0.000382	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CD—liver cancer	0.000213	0.000376	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—ALB—liver cancer	0.000211	0.000371	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—F2—liver cancer	0.00021	0.000371	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CRABP1—liver cancer	0.000207	0.000365	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRKCE—liver cancer	0.000204	0.000359	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CD—liver cancer	0.000201	0.000355	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CG—liver cancer	0.000201	0.000355	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CD—liver cancer	0.000195	0.000343	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CB—liver cancer	0.000193	0.000341	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IGF2—liver cancer	0.000193	0.00034	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CB—liver cancer	0.000186	0.000328	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CPT1B—liver cancer	0.000183	0.000323	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GLUL—liver cancer	0.000183	0.000323	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HPGDS—liver cancer	0.000181	0.000319	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CSF2—liver cancer	0.00018	0.000318	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—RAF1—liver cancer	0.00018	0.000317	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRKCE—liver cancer	0.000179	0.000315	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—H2AFX—liver cancer	0.000178	0.000313	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—IL2—liver cancer	0.000178	0.000313	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CD—liver cancer	0.000177	0.000312	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NR1H4—liver cancer	0.000177	0.000312	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CB—liver cancer	0.000176	0.00031	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTA3—liver cancer	0.000174	0.000306	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CB—liver cancer	0.00017	0.000299	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF2—liver cancer	0.000169	0.000299	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL2—liver cancer	0.000161	0.000284	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PSMA4—liver cancer	0.000161	0.000284	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PSMD10—liver cancer	0.000161	0.000284	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TERT—liver cancer	0.000161	0.000283	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTA4—liver cancer	0.000159	0.00028	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CSF2—liver cancer	0.000158	0.000279	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—RAF1—liver cancer	0.000158	0.000278	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GOT2—liver cancer	0.000157	0.000276	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—H2AFX—liver cancer	0.000156	0.000275	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—IL2—liver cancer	0.000156	0.000275	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTA2—liver cancer	0.000155	0.000273	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CB—liver cancer	0.000154	0.000272	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTA1—liver cancer	0.000149	0.000264	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NAT2—liver cancer	0.000148	0.000261	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP2E1—liver cancer	0.000147	0.00026	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KDR—liver cancer	0.000147	0.000259	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK14—liver cancer	0.000146	0.000257	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ESR1—liver cancer	0.000143	0.000252	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALDOB—liver cancer	0.000142	0.00025	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL2—liver cancer	0.000142	0.00025	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—F2—liver cancer	0.000141	0.000249	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TERT—liver cancer	0.000141	0.000249	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYCS—liver cancer	0.000138	0.000243	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APC—liver cancer	0.000135	0.000239	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CG—liver cancer	0.000135	0.000239	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GGT1—liver cancer	0.000135	0.000238	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GOT1—liver cancer	0.000135	0.000238	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CRABP1—liver cancer	0.000135	0.000238	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KDR—liver cancer	0.000129	0.000227	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK14—liver cancer	0.000128	0.000226	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—BRAF—liver cancer	0.000127	0.000224	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ESR1—liver cancer	0.000126	0.000222	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—F2—liver cancer	0.000124	0.000219	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTP1—liver cancer	0.000121	0.000214	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HMOX1—liver cancer	0.00012	0.000211	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CD—liver cancer	0.000119	0.00021	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CG—liver cancer	0.000119	0.00021	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APC—liver cancer	0.000119	0.00021	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HPGDS—liver cancer	0.000118	0.000208	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CA—liver cancer	0.000118	0.000208	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SERPINE1—liver cancer	0.000118	0.000208	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—KRAS—liver cancer	0.000116	0.000205	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CA—liver cancer	0.000113	0.0002	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—BRAF—liver cancer	0.000112	0.000197	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTM1—liver cancer	0.000112	0.000197	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CA—liver cancer	0.000107	0.000189	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RAF1—liver cancer	0.000106	0.000187	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP1A1—liver cancer	0.000106	0.000187	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PSMA4—liver cancer	0.000105	0.000186	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PSMD10—liver cancer	0.000105	0.000186	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CD—liver cancer	0.000104	0.000184	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CB—liver cancer	0.000104	0.000183	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MTOR—liver cancer	0.000104	0.000183	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CA—liver cancer	0.000103	0.000182	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SERPINE1—liver cancer	0.000103	0.000182	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GOT2—liver cancer	0.000102	0.000181	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—KRAS—liver cancer	0.000102	0.00018	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HRAS—liver cancer	9.9e-05	0.000175	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MTHFR—liver cancer	9.87e-05	0.000174	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDKN1B—liver cancer	9.73e-05	0.000172	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPARA—liver cancer	9.68e-05	0.000171	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP2E1—liver cancer	9.63e-05	0.00017	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—AKT1—liver cancer	9.63e-05	0.00017	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CASP3—liver cancer	9.54e-05	0.000168	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL2—liver cancer	9.53e-05	0.000168	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL6—liver cancer	9.48e-05	0.000167	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CA—liver cancer	9.4e-05	0.000166	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RAF1—liver cancer	9.33e-05	0.000164	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCND1—liver cancer	9.29e-05	0.000164	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—JUN—liver cancer	9.27e-05	0.000163	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—AKT1—liver cancer	9.26e-05	0.000163	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CTNNB1—liver cancer	9.2e-05	0.000162	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CB—liver cancer	9.11e-05	0.000161	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MTOR—liver cancer	9.11e-05	0.000161	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MMP9—liver cancer	9.01e-05	0.000159	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYCS—liver cancer	9.01e-05	0.000159	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDKN1A—liver cancer	8.98e-05	0.000158	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GGT1—liver cancer	8.84e-05	0.000156	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GOT1—liver cancer	8.84e-05	0.000156	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK8—liver cancer	8.77e-05	0.000155	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—AKT1—liver cancer	8.74e-05	0.000154	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HRAS—liver cancer	8.69e-05	0.000153	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDKN1B—liver cancer	8.55e-05	0.000151	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—AKT1—liver cancer	8.45e-05	0.000149	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CASP3—liver cancer	8.38e-05	0.000148	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL2—liver cancer	8.36e-05	0.000147	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6—liver cancer	8.32e-05	0.000147	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CG—liver cancer	8.29e-05	0.000146	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCND1—liver cancer	8.15e-05	0.000144	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—JUN—liver cancer	8.14e-05	0.000143	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—VEGFA—liver cancer	8.1e-05	0.000143	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CTNNB1—liver cancer	8.07e-05	0.000142	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—STAT3—liver cancer	8.02e-05	0.000141	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPARG—liver cancer	8e-05	0.000141	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTP1—liver cancer	7.94e-05	0.00014	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MMP9—liver cancer	7.92e-05	0.00014	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDKN1A—liver cancer	7.89e-05	0.000139	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HMOX1—liver cancer	7.83e-05	0.000138	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK8—liver cancer	7.7e-05	0.000136	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AKT1—liver cancer	7.68e-05	0.000135	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MYC—liver cancer	7.45e-05	0.000131	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TGFB1—liver cancer	7.43e-05	0.000131	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTM1—liver cancer	7.3e-05	0.000129	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CD—liver cancer	7.29e-05	0.000129	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALB—liver cancer	7.19e-05	0.000127	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—VEGFA—liver cancer	7.11e-05	0.000125	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—STAT3—liver cancer	7.04e-05	0.000124	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP1A1—liver cancer	6.92e-05	0.000122	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KRAS—liver cancer	6.88e-05	0.000121	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MYC—liver cancer	6.54e-05	0.000115	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TGFB1—liver cancer	6.52e-05	0.000115	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MTHFR—liver cancer	6.45e-05	0.000114	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CB—liver cancer	6.35e-05	0.000112	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARA—liver cancer	6.33e-05	0.000112	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CA—liver cancer	6.32e-05	0.000111	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TP53—liver cancer	6.12e-05	0.000108	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KRAS—liver cancer	6.04e-05	0.000107	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HRAS—liver cancer	5.85e-05	0.000103	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6—liver cancer	5.6e-05	9.87e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CA—liver cancer	5.55e-05	9.79e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CG—liver cancer	5.42e-05	9.56e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TP53—liver cancer	5.37e-05	9.47e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARG—liver cancer	5.23e-05	9.22e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKT1—liver cancer	5.17e-05	9.11e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HRAS—liver cancer	5.14e-05	9.06e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6—liver cancer	4.92e-05	8.67e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CD—liver cancer	4.77e-05	8.4e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALB—liver cancer	4.7e-05	8.29e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKT1—liver cancer	4.53e-05	8e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CB—liver cancer	4.15e-05	7.32e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CA—liver cancer	3.87e-05	6.83e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AKT1—liver cancer	3.16e-05	5.58e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CA—liver cancer	2.53e-05	4.46e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKT1—liver cancer	2.07e-05	3.65e-05	CbGpPWpGaD
